Advanced Peptide Synthesis Service Supports Innovation in Pharmaceutical and Biotechnology Research

With the rapid development of modern biotechnology, the demand for reliable and efficient peptide synthesis service solutions continues to grow across pharmaceutical, medical research, and life science industries. Researchers and companies increasingly rely on professional peptide production platforms to obtain high-quality peptides for drug discovery, diagnostic development, and customized biological studies.

2026-07-28

JiuZhou Pharma has been included in the FTSE4Good Index Series for the third consecutive year

2026-07-23

Haisco's Cipepofol Receives U.S. FDA Approval with CDMO Support from Jiuzhou Pharma

2026-07-21

Global Peptide Therapeutics Market Surges as CDMOs Invest in Specialized Peptide Drug Platform Capabilities

The pharmaceutical industry is witnessing a significant paradigm shift, with peptide therapeutics emerging as a powerful modality for treating a wide range of diseases. This growth is underscored by a wave of investment and strategic expansion in specialized peptide drug platform technologies. From AI-driven discovery to large-scale GMP manufacturing, the infrastructure for these complex molecules is rapidly maturing. In a strong vote of confidence for the sector, Syneron Bio recently secured a massive $150 million Series B financing round to advance its AI-driven peptide drug platform .

2026-07-21

De-Risking Early Phase Development

Date: 8 July 2026 Venue: Parc Cientific de Barcelona, Sala Dolors Aleu

2026-07-01

CPHI South East Asia 2026

Date: 8-10 July 2026 Venue: 60 New Rachadapisek Road, Klongtoey, Bangkok, Thailand

2026-07-01

SynTech

Date: 6-8 July 2026 Venue: Old Royal Naval College, Greenwich, London, UK

2026-07-01

ISPC 2026

Date: 1-3 July 2026 Venue:Act City Hamamatsu, Hamamatsu City, Shizuoka Prefecture, Japan

2026-07-01

InterBiz Bio Partnering

Date: 1-3 July 2026 Venue: Phoenix Island Jeju, Building B, 107, Seopjikoji-ro, Seongsan-eup, Seogwipo-si, Jeju-do, Republic of Korea

2026-07-01

Peptide Technology Platforms Power the Next Wave of Therapeutic Innovation

The pharmaceutical industry is witnessing an unprecedented surge in peptide-based therapeutics, driven by their unique ability to combine the target specificity of biologics with the manufacturing efficiency of small molecules. As GLP-1 agonists and other peptide drugs achieve blockbuster success,

2026-06-29

Peptide Drug Development Accelerates as Next-Generation Therapeutics Reshape the Pharmaceutical Landscape

The global pharmaceutical landscape is being reshaped by the rising prominence of peptide-based therapeutics, driven by their success in treating chronic diseases such as diabetes, obesity, and cancer. As more peptide candidates enter clinical pipelines and gain regulatory approval,

2026-06-22

Small Molecule CDMO Services Drive Agility and Innovation in a Complex Drug Development Landscape

The global pharmaceutical industry is undergoing a profound shift, yet small molecule active pharmaceutical ingredients (APIs) remain the backbone of modern therapeutics. As drug pipelines grow more complex and the demand for targeted therapies rises, the strategic role of small molecule CDMO services has never been more critical. From early development to commercial supply, these services are enabling faster timelines, regulatory success, and supply chain resilience.

2026-06-15